Natreon’s Crominex3+ Receives Patent


New Brunswick, NJ—Crominex3+, a Natreon ingredient that according to the company provides cardiovascular health benefits, received a U.S. Patent, according to a press release.

The press release states that Crominex3+ is a composition of trivalent chromium chloride and alma and shilajit extracts that affect the improvement of lipid profile and endothelial function. The new patent and 7 clinical studies on Crominex®3+ institute the ingredient as an optimal product for heart health support, according to the release.

“We are glad that USPTO has granted a well-deserved patent for cardiovascular health benefits of Crominex3+, the most efficacious of several chromium supplements from the market,” Dr. Sanni Raju, CEO of Natreon, said in the release. “Crominex3+ has amazing synergistic activity that showed significant improvement in endothelial function, lipid profile, hsCRP, as well as HbA1c, which are all important factors for cardiovascular health. Synergistic activity of Crominex3+ is achieved by using totally natural materials.”

The addition of this patent marks number 28 in active domestic and international patents for Natreon products.


Please enter your comment!
Please enter your name here